will tirzepatide be banned FDA moves to remove GLP-1 medications from 503B Bulks List The FDA has declared an

Creating a high-quality, stable biosimilar (or in this case, a complex small-molecule peptide) and a device that passes Health Canadas scrutiny is no small feat

The 5As Framework (assess, advise, agree, assist, and arrange) is useful to guide the patient-clinician interaction to create foundation for long-term adherence to behavior change

L-Carnitine L-Tartrate Liquid Description L-carnitine L-Tartrate, chromium and vitamins containing liquid with sweeteners

Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer